Silver Book Fact

“Coronary heart disease spending has increased more than 40% over the past 15 years, and, as a whole, the health improvements have been well worth the costs. Over the entire population, spending on coronary heart disease and its major risk factors has resulted in a life-expectancy increase of 0.62 years, at an incremental cost of $43,600 per year of life gained. Life expectancy following a myocardial infraction has increased by nearly a year, at an incremental cost of $24,800 per life-year gained.”

Rosen, Allison B., David M. Cutler, Douglas M. Norton, Hsou Mei Hu, and Sandeep Vijan. The Value Of Coronary Heart Disease Care For The Elderly: 1987-2002. Health Affairs. 2007; 26(1): 111-123

Reference

Title
The Value Of Coronary Heart Disease Care For The Elderly: 1987-2002
Publication
Health Affairs
Publisher
Project HOPE
Publication Date
2007
Authors
Rosen, Allison B., David M. Cutler, Douglas M. Norton, Hsou Mei Hu, and Sandeep Vijan
Volume & Issue
Volume 26, Issue 1
Pages
111-123

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • The rate of hospitalization from heart failure before and after transcatheter mitral valve repair (TMVR) decreases 73% (per patient year) in patients at prohibitive surgical risk.
     
  • Antihypertensive treatment has generated a benefit-to-cost ratio of at least 6:1 (6:1 in women and 10:1 in men).  
  • Use of ACE inhibitor drugs for people with congestive heart failure helped avoid $9,000 per person in hospital costs over a 3-year period and reduced deaths by 16%.  
  • Statin treatment soon after an acute heart attack reduces the risk of fatal heart disease or a recurrent heart attack by 24%.  
  • From approval in 2011 through 2015 >54,000 TAVRs were performed in 418 centers in 48 states